{
    "clinical_study": {
        "@rank": "100862", 
        "arm_group": [
            {
                "arm_group_label": "Sensor alone", 
                "arm_group_type": "Active Comparator", 
                "description": "Glucose sensor site will not have Insupatch"
            }, 
            {
                "arm_group_label": "Sensor with Insupatch", 
                "arm_group_type": "Experimental", 
                "description": "Glucose sensor site with Insupatch"
            }
        ], 
        "brief_summary": {
            "textblock": "This study will investigate the effect of wearing a small warming patch, the InsuPatch, at\n      the site of the continuous glucose monitor (CGM), also called a sensor. Specifically, we\n      will be looking to see if using the InsuPatch (IP) improves the accuracy of the continuous\n      glucose monitor."
        }, 
        "brief_title": "Warming up to Sensors: Does Site Warming Improve Continuous Glucose Monitor Performance?", 
        "completion_date": {
            "#text": "September 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Type 1 Diabetes", 
        "condition_browse": {
            "mesh_term": [
                "Diabetes Mellitus", 
                "Diabetes Mellitus, Type 1"
            ]
        }, 
        "detailed_description": {
            "textblock": "Hypotheses:\n\n        1. Warming of the skin and subcutaneous tissue with the InsuPatch device will improve the\n           accuracy of a CGM as compared to a CGM used alone when both are calibrated with a\n           standard laboratory quality glucose measuring reference standard.\n\n        2. Warming of the skin and subcutaneous tissue with the InsuPatch device will reduce the\n           lag time of the CGM, as compared to a CGM used alone when both are calibrated with a\n           standard laboratory quality glucose measuring reference standard.\n\n        3. The combination of the InsuPatch device and a CGM will be well-tolerated and not cause\n           skin irritation."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Clinical diagnosis of type 1 diabetes and using daily insulin therapy for at least 12\n             months.\n\n          2. Age 8 years to less than 45 years old.\n\n          3. Subject understands the study protocol and agree to comply with it.\n\n          4. Subject is on insulin pump or injection-based basal-bolus therapy\n\n          5. Subject comprehends written English.\n\n          6. For females, subject not intending to become pregnant during the study.\n\n          7. Informed Consent Form signed by the subject\n\n          8. No history of altered skin integrity, poor wound healing, adhesive allergy, or\n             previous infection from sensor wear.\n\n          9. Hemoglobin A1C \u226410%\n\n        Exclusion Criteria:\n\n          1. The presence of a significant medical disorder that in the judgment of the\n             investigator will affect the wearing of the sensors or the completion of any aspect\n             of the protocol\n\n          2. The presence of any of the following diseases:\n\n             a. Current use of systemic corticosteroids (within the last week) b. Other major\n             illness that in the judgment of the investigator might interfere with the completion\n             of the protocol i. Adequately treated thyroid disease and celiac disease do not\n             exclude subjects from enrollment\n\n          3. Inpatient psychiatric treatment in the past 6 months for either the subject or the\n             subject's primary care giver (i.e., parent or guardian)\n\n          4. Current or past use of a continuous glucose sensor is not an exclusion criterion.\n\n          5. Active skin condition that would affect sensor placement\n\n          6. Use of acetaminophen or Vitamin C supplement within the last 7 days\n\n          7. Subject is deemed by the Investigator to be unwilling or unable to follow the\n             protocol;\n\n          8. Pregnancy A negative urine pregnancy test will be required for all premenopausal\n             women who are not surgically sterile. Subjects who become pregnant will be\n             discontinued from the study.\n\n             -"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "44 Years", 
            "minimum_age": "8 Years"
        }, 
        "enrollment": {
            "#text": "20", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 26, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01954459", 
            "org_study_id": "1306012208"
        }, 
        "intervention": [
            {
                "arm_group_label": "Sensor with Insupatch", 
                "description": "Device which applies local heating at 40 degrees Celsius to the vicinity of the subcutaneous site of glucose sensor.", 
                "intervention_name": "Insupatch", 
                "intervention_type": "Device"
            }, 
            {
                "arm_group_label": "Sensor alone", 
                "description": "Glucose sensor inserted without warming patch", 
                "intervention_name": "Continuous glucose sensor", 
                "intervention_type": "Device"
            }
        ], 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "Type 1 diabetes", 
            "Continuous glucose sensor", 
            "Insupatch"
        ], 
        "lastchanged_date": "September 26, 2013", 
        "location": {
            "contact": {
                "email": "lori.carria@yale.edu", 
                "last_name": "Lori Carria, MS", 
                "phone": "203-737-3595"
            }, 
            "facility": {
                "address": {
                    "city": "New Haven", 
                    "country": "United States", 
                    "state": "Connecticut", 
                    "zip": "06520"
                }, 
                "name": "Yale University School of Medicine"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Warming up to Sensors: Does Site Warming Improve Continuous Glucose Monitor Performance?", 
        "overall_contact": {
            "email": "lori.carria@yale.edu", 
            "last_name": "Lori Carria", 
            "phone": "203-737-3595"
        }, 
        "overall_official": {
            "affiliation": "Yale University", 
            "last_name": "Camille Michaud, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 0", 
        "primary_completion_date": {
            "#text": "March 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Point accuracy of the continuous glucose monitor plus Insupatch (CGM+IP) by mean absolute relative difference (MARD) calculation of sensors with and without IP use, comparing sensor glucose readings and signal data to serum Yellow Springs Instrument (YSI) glucose measurements, with each subject acting as his or her own control.", 
            "measure": "Point accuracy of the continuous glucose monitor plus Insupatch (CGM+IP) by mean absolute relative difference (MARD) calculation of sensors with and without IP use.", 
            "safety_issue": "No", 
            "time_frame": "4 hours after lunch, 8 hours after breakfast"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01954459"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Yale University", 
            "investigator_full_name": "Camille Michaud", 
            "investigator_title": "Post-doctoral fellow", 
            "responsible_party_type": "Sponsor-Investigator"
        }, 
        "source": "Yale University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Camille Michaud", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2013", 
        "study_design": "Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label", 
        "study_type": "Interventional", 
        "verification_date": "September 2013"
    }
}